2002
DOI: 10.1590/s0100-879x2002000100010
|View full text |Cite
|
Sign up to set email alerts
|

Short-term evaluation of non-absorbable microgranular hydroxyapatite infiltration in the guinea pig subepidermal abdominal region

Abstract: Non-absorbable microgranular hydroxyapatite was infiltrated into the subepidermal abdominal region of guinea pigs in order to assess the possibility of using this material to correct deficiencies in orbital volume. Microgranular hydroxyapatite (2.0 ml) was subepidermally infiltrated into the abdominal region of 20 guinea pigs. The animals were divided into four experimental groups of 5 animals each, which were killed 7 (G1), 15 (G2), 30 (G3) and 60 (G4) days after infiltration. The area and the largest and sma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0
1

Year Published

2012
2012
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 3 publications
1
2
0
1
Order By: Relevance
“…These results indicated a predominance of mononuclear cells in samples from eight days and tissue organization around the biomaterial with tendency for encapsulation with ever-smaller portions of HAP-91 ® , as well as fibrous capsule formation and mild inflammatory reaction, being observed in samples from 21 and 49 days, as reported by Li et al (1999), Xavier et al (2002), Berlin et al (2006), Carlo et al (2007), Dayan & Bassichis (2008), Vogt et al (2008), Jones (2009), Qu et al (2010 and Khashaba et al (2011).…”
Section: Resultssupporting
confidence: 78%
See 1 more Smart Citation
“…These results indicated a predominance of mononuclear cells in samples from eight days and tissue organization around the biomaterial with tendency for encapsulation with ever-smaller portions of HAP-91 ® , as well as fibrous capsule formation and mild inflammatory reaction, being observed in samples from 21 and 49 days, as reported by Li et al (1999), Xavier et al (2002), Berlin et al (2006), Carlo et al (2007), Dayan & Bassichis (2008), Vogt et al (2008), Jones (2009), Qu et al (2010 and Khashaba et al (2011).…”
Section: Resultssupporting
confidence: 78%
“…The fibrous capsule formation is related to a number of factors such as the size, shape and texture of the implant as well as its chemical properties, porosity, deployment location, and the physical and chemical stimuli caused by the implant, being an expected response to the material within the normal range (Li et al, 1999;Carlo et al, 2007;Qu et al, 2010;Khashaba et al, 2011). According to Xavier et al (2002), it is likely that this capsule prevents the leakage of the biomaterial, therefore reducing the inflammatory response near the site of application and thereby reducing the occurrence of granulomas.…”
Section: Resultsmentioning
confidence: 99%
“…A long technological challenge has been traversed until the production method of Nanoskin, material resulting from the synthesis process and which, thus, is not limited, as it would be in the case of other materials such as natural hydroxyapatite. 3 The strong initial appeal of integrated implants 3 was the starting point so that new materials were studied [4][5][6] , opening a wide range of research seeking for the ideal biomaterial. The present study showed that Nanoskin is a biomaterial that can be well tolerated by the orbital cavity, not having caused any death or showing that the overall health of the animal had been affected, despite the need for biochemical and histology exams of target organs to confirm that.…”
Section: Discussionmentioning
confidence: 99%
“…Alguns estudos analisaram implantes de materiais gelatinosos, como o polietileno gel injetado no subcutâneo de cobaias (6,7) e esferas de polietileno gel, colocados em cavidades anoftálmicas de coe lhos (4) , ambos com boa resposta tecidual. Implantes não rígidos, feitos de silicone no estado gelatinoso já foram largamente utilizados em outros locais do corpo humano, como os implantes mamários, em mastoplastias de aumento (8) .…”
unclassified